Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine
NCT07416110 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 912
Last updated 2026-02-17
Summary
To evaluate immunogenicity consistency between three consecutive batches of commercial-scale productions for Sinovac Rabies vaccine
Conditions
- Rabies (Healthy Volunteers)
Interventions
- BIOLOGICAL
-
Sinovac rabies vaccine
Three batchs of Rabies Vaccine (Serum-free Vero Cell), Freeze-dried using five doses of PEP schedules
Sponsors & Collaborators
-
Sinovac Biotech Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-04
- Primary Completion
- 2026-09-30
- Completion
- 2027-06-30
Countries
- China
Study Locations
More Related Trials
-
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen
NCT07055893 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine
NCT05547815 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)
NCT07028801 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen
NCT01067079 ·Status: TERMINATED
-
Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
NCT07055880 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried
NCT07021703 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children
NCT02991872 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
NCT04852068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)
NCT05969626 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Immunogenicity of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans
NCT02288286 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)
NCT06177249 ·Status: COMPLETED ·Phase: PHASE3
-
Purified Rabies Vaccine for Human Use (Chick-embryo Cell)
NCT00345319 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans
NCT02281396 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)
NCT06078423 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried in a Population Aged 10 to 60 Years
NCT07275645 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults
NCT01680016 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)
NCT07338786 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine
NCT01339312 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine .
NCT03971370 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
NCT07120464 ·Status: RECRUITING
-
A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried in a Population Aged 10-60 Years
NCT06132789 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age
NCT02177032 ·Status: COMPLETED ·Phase: PHASE3
-
Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year
NCT03700242 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally
NCT05937113 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried
NCT05667974 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3